DALLAS--(BUSINESS WIRE)--Zix Corporation (ZixCorp), (NASDAQ: ZIXI), the leader in email encryption services, was selected by ICON Central Laboratories to provide lab reports through an encrypted email solution for select sites participating in clinical trials. ICON Central Laboratories, a division of ICON plc, is a global central laboratory exclusively engaged in clinical trial testing. With laboratories located in New York, Dublin, Singapore, India and China, ICON Central Laboratories has tested and reported lab results for clinical trial subjects in more than 40,000 sites worldwide.
